A document summarising the challenges and solutions the the collection of starting materials for ATMP manufacture though apheresis.

A British Pharmacopeia whitepaper for the application of flow cytometry for the cell and gene therapy community.

This paper highlights the major themes found in designing and applying flow cytometric analysis for cellular therapies and discusses practical solutions to common problems.

Horizon Scanning is the systematic process of identifying new medicines or technologies in development. This information is useful to clinical trials sponsors ATMP developers and manufacturers organisations aspiring to hold ATMP marketing authorisations as well as to NHS group members and beyond.

E-learning on the NHS e-learning platform e-learning for healthcare (registration required) giving the user an overview of the requirements for labelling human tissues and cells for use as starting materials for advanced therapy medicinal products using the ISBT 128 system.

A visual guide to the preparation administration and disposal of non-cellular genetically modified organisms (GMOs) in a clinical setting.

This review highlights the need for appropriate patient and public education on the various aspects of cell and gene therapies. Patient and public perceptions of these therapies alongside evidence of clinical and cost-effectiveness will be central to their uptake and use.

A training resource on the importance of correctly thawing and inspecting cell therapy medicinal products.

A training video demonstrating the visual inspection of a cell therapy product prior to infusion.